Rezultati - Weihui Shentu
- Showing 1 - 4 results of 4
-
1
-
2
Modulating Lysine Crotonylation in Cardiomyocytes Improves Myocardial Outcomes od Wenqian Cai, Dacai Xu, Chui Zeng, Fan Liao, Ruiqi Li, Yingjiong Lin, Yue Zhao, Wenyan Dong, Qingwen Wang, Haili Yang, Daqiang Wen, Jianbiao Gu, Weihui Shentu, Yu H, Xiaochun Zhang, Jianrui Wei, Jinzhu Duan
Izdano 2022Artigo -
3
Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype od Owen J. T. McCarty, Robert B. Conley, Weihui Shentu, Garth W. Tormoen, Dao-gang Zha, Aris Xie, Yue Qi, Yan Zhao, Chad L. Carr, Todd Belcik, Douglas R. Keene, Philip G. de Groot, Jonathan R. Lindner
Izdano 2010Artigo -
4
Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib od Yllka Latifi, Federico Moccetti, Melinda Wu, Aris Xie, William Packwood, Yue Qi, Koya Ozawa, Weihui Shentu, Eran Brown, Toshiaki Shirai, Owen J. T. McCarty, Zaverio M. Ruggeri, Javid J. Moslehi, Junmei Chen, Brian J. Druker, José A. López, Jonathan R. Lindner
Izdano 2019Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Platelet
Von Willebrand factor
Biology
Cardiology
Chemistry
Endocrinology
Endothelial dysfunction
Endothelium
Platelet activation
Amino acid
Angiopathy
Apocynin
Biochemistry
Biotechnology
Cell biology
Dasatinib
Diabetes mellitus
Endothelial activation
Ex vivo
Immunology
In vivo
Inflammation
Intravital microscopy
Lysine
Microbubbles
Microcirculation
Myocardial infarction
NADPH oxidase